Osteomalacia As a Rare Complication of Intravenous Iron Supplementation
Insights in Blood Disorders · 2022
DOI: 10.33425/2771-9073.1002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Insights in Blood Disorders, 2022. Verfasst von Philippa Tepper und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Iron deficiency (ID) and Iron deficiency anaemia (IDA) are very common among patients with chronic heart failure, chronic kidney disease, inflammatory bowel disease and pre-menopausal and pregnant women. Both ID and IDA can be managed effectively with intravenous Iron supplementation, which has been shown to be superior to oral Iron therapy. We are presenting a patient in her third trimester of pregnancy, who was diagnosed with IDA and treated with intravenous ferric carboxymaltose. This patient developed a rare complication of osteomalacia, which presented as a diagnostic challenged leading to ongoing symptoms until the appropriate diagnosis was made.
Zitieren
APA
Tepper, P., Ekaldious, A., & Tepper, B. (2022). Osteomalacia As a Rare Complication of Intravenous Iron Supplementation. Insights in Blood Disorders. https://doi.org/10.33425/2771-9073.1002
Vancouver
Tepper P, Ekaldious A, Tepper B. Osteomalacia As a Rare Complication of Intravenous Iron Supplementation. Insights in Blood Disorders. 2022. doi:10.33425/2771-9073.1002
BibTeX
@article{Tepper2022,
author = {Tepper, Philippa and Ekaldious, Adel and Tepper, Bianca},
title = {Osteomalacia As a Rare Complication of Intravenous Iron Supplementation},
journal = {Insights in Blood Disorders},
year = {2022},
doi = {10.33425/2771-9073.1002}
}
EUVIMED